Structure of PDB 8ojh Chain B Binding Site BS02 |
|
|
Ligand ID | VP9 |
InChI | InChI=1S/C14H13N3O5/c1-22-8-4-2-6(15)10-11(8)14(21)17(13(10)20)7-3-5-9(18)16-12(7)19/h2,4,7H,3,5,15H2,1H3,(H,16,18,19)/t7-/m0/s1 |
InChIKey | JQKAGYPIPZUGHW-ZETCQYMHSA-N |
SMILES | Software | SMILES |
---|
OpenEye OEToolkits 2.0.7 | COc1ccc(c2c1C(=O)N(C2=O)[C@H]3CCC(=O)NC3=O)N | CACTVS 3.385 | COc1ccc(N)c2C(=O)N([C@H]3CCC(=O)NC3=O)C(=O)c12 | CACTVS 3.385 | COc1ccc(N)c2C(=O)N([CH]3CCC(=O)NC3=O)C(=O)c12 | OpenEye OEToolkits 2.0.7 | COc1ccc(c2c1C(=O)N(C2=O)C3CCC(=O)NC3=O)N |
|
Formula | C14 H13 N3 O5 |
Name | 4-azanyl-2-[(3~{S})-2,6-bis(oxidanylidene)piperidin-3-yl]-7-methoxy-isoindole-1,3-dione |
ChEMBL | |
DrugBank | |
ZINC |
|
PDB chain | 8ojh Chain B Residue 502
[Download ligand structure]
[Download structure with residue number starting from 1]
[View ligand structure]
|
|
|
|
Enzyme Commision number |
? |
|
|
Biological Process |
GO:0016567 |
protein ubiquitination |
GO:0030177 |
positive regulation of Wnt signaling pathway |
GO:0031333 |
negative regulation of protein-containing complex assembly |
GO:0031334 |
positive regulation of protein-containing complex assembly |
GO:0034766 |
negative regulation of monoatomic ion transmembrane transport |
GO:0035641 |
locomotory exploration behavior |
GO:0043161 |
proteasome-mediated ubiquitin-dependent protein catabolic process |
GO:1902607 |
negative regulation of large conductance calcium-activated potassium channel activity |
|
|